Clin Infect Dis, 2022, 75(1):e1-e9
SARS-CoV-2-specific T cells and antibodies in COVID-19 protection: a prospective study
During the ongoing coronavirus disease COVID-19 pandemic, many individuals were infected with and have cleared the virus, developing virus-specific antibodies and effector/memory T cells. An important unanswered question is what levels of T cell and antibody responses are sufficient to protect from the infection.
Scopus: 2-s2.0-85137124808

IBCH: 9977
Ссылка на статью в журнале: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciac278/6567222
Кол-во цитирований на 04.2025: 24
Данные статьи проверены модераторами 2022-05-04
Список научных проектов, где отмечена публикация
- DZM-30-3. . Сommercial.
- 075-15-2020-899. . Сommercial.
- KNP-06/21. . Сommercial.